Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 1997

View Archived Issues

NIH licenses method of reducing aminoglycoside-induced hearing loss

NIH licenses PTC gene for cancer diagnosis and therapy

NIH seeks licensees for method of determining susceptibility to bipolar disease

Licensees sought for diagnostic aid for AD

NIH seeks licensees for method of characterizing/screening/detecting DNA-binding ligands

Cellegy Pharmaceuticals: FY96 product highlights

Columbia Laboratories: FY96 product highlights

CV Therapeutics: FY96 product highlights

Ligand Pharmaceuticals: FY96 product highlights

Oncor: FY96 product highlights

Sheffield Medical Technologies: FY96 product highlights

Titan Pharmaceuticals: FY96 product highlights

VIMRx: FY96 product highlights

Aradigm's SmartMist covered by U.S. patent

PDL and Teijin agreement for MAb to E. coli toxin

AMBI's Cardia Salt Alternative associated with reduced blood pressure

NitroMed/J&J divisions collaborate on NSAID/NO donor compounds

Agents for cerebral ischemia and neurodegenerative disorders from Boehringer Ingelheim

SmithKline Beecham claims novel endothelin antagonists

Small-molecule drug discovery collaboration between Chiroscience and Alcon

Quinolone PDE IV/TNF inhibitors from Chiroscience

Lilly describes agents for postmenopausal syndrome

Fujisawa reports antiulcer agents

Zila completes Cygnus acquisition

Selfadministration device for Imitrex available in the U.S.

Taisho/Ikeda Mohando describe anti-H. pylori agent

Antimicrobial/antineoplastic antibiotic discovered by Ajinomoto

Sugen receives patent coverage for GRB2 cancer target

ID's strep vaccine safe and effective in animals

Mylan and Meridian reach generic drug agreement

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...